Literature DB >> 6815268

Procedures for the purification of interleukin 3 to homogeneity.

J N Ihle, J Keller, L Henderson, F Klein, E Palaszynski.   

Abstract

A procedure is described for the routine purification of IL 3 to homogeneity from WEHI-3-conditioned media. The techniques employed include ammonium sulfate fractionation, DEAE-cellulose, hydroxylapatite, and G-75 Sephadex column chromatography. The last step in purification involves chromatography on C18 hydrophobic supports in RP-HPLC systems, which results in the coelution of a protein peak and IL 3 activity. This purification sequence results in approximately a 1,000,000-fold purification from the initial starting material with yields of 5 to 10% of the initial activity. typically, 150 liters of conditioned media yields 2 to 10 micrograms of IL 3. The purified material was homogeneous by SDS-PAGE analysis and had an apparent m.w. of 28,000. Purified IL 3 had a specific activity of approximately 0.05 ng/unit of activity. Additional criteria used to establish the relationship of the 28,000-dalton protein to IL 3 include the ability of an antiserum against IL 3 to concomitantly immunoprecipitate the iodinated protein and to inhibit its biologic activity as well as the ability of the iodinated protein to bind specifically to cell lines known to require IL 3 for growth.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6815268

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  80 in total

1.  Haematopoietic stem cell proliferation regulators investigated using an in vitro assay.

Authors:  S Robinson; A Riches
Journal:  J Anat       Date:  1991-02       Impact factor: 2.610

Review 2.  Hematopoietic cytokines.

Authors:  Donald Metcalf
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

3.  Differential effects of microenvironmentally presented interleukin 3 versus soluble growth factor on primitive human hematopoietic cells.

Authors:  T Otsuka; J D Thacker; C J Eaves; D E Hogge
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

4.  Rat IL-3 stimulates the growth of rat mucosal mast cells in culture.

Authors:  D M Haig; C McMenamin; J Redmond; D Brown; I G Young; S D Cohen; A J Hapel
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

5.  Distinct mechanisms may account for the growth-promoting activity of interleukin 3 on cells of lymphoid and myeloid origin.

Authors:  R Palacios; J Garland
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

Review 6.  The colony-stimulating factors and cancer.

Authors:  Donald Metcalf
Journal:  Cancer Immunol Res       Date:  2013-12       Impact factor: 11.151

7.  The in vivo functions and properties of persisting cell-stimulating factor.

Authors:  R M Crapper; I Clark-Lewis; J W Schrader
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

8.  Isolation and characterization of a mouse cDNA clone that expresses mast-cell growth-factor activity in monkey cells.

Authors:  T Yokota; F Lee; D Rennick; C Hall; N Arai; T Mosmann; G Nabel; H Cantor; K Arai
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

9.  Multiple hemopoietic lineages are found after stimulation of mouse bone marrow precursor cells with interleukin 3.

Authors:  M B Prystowsky; G Otten; M F Naujokas; J Vardiman; J N Ihle; E Goldwasser; F W Fitch
Journal:  Am J Pathol       Date:  1984-11       Impact factor: 4.307

Review 10.  The control of hematopoiesis and leukemia: from basic biology to the clinic.

Authors:  L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.